Cargando…

Toll-like receptor 4 (TLR4): new insight immune and aging

TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4 not only engages with exogenous ligands at the cellular membrane’s surface but also interacts with intracellular ligands, initiating intricate intracellular signaling cascades. Through MyD88, an adaptor protein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyo-Jin, Kim, Hyemin, Lee, Jeong-Hyung, Hwangbo, Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668412/
https://www.ncbi.nlm.nih.gov/pubmed/38001481
http://dx.doi.org/10.1186/s12979-023-00383-3
_version_ 1785149125116821504
author Kim, Hyo-Jin
Kim, Hyemin
Lee, Jeong-Hyung
Hwangbo, Cheol
author_facet Kim, Hyo-Jin
Kim, Hyemin
Lee, Jeong-Hyung
Hwangbo, Cheol
author_sort Kim, Hyo-Jin
collection PubMed
description TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4 not only engages with exogenous ligands at the cellular membrane’s surface but also interacts with intracellular ligands, initiating intricate intracellular signaling cascades. Through MyD88, an adaptor protein, TLR4 activates transcription factors NF-κB and AP-1, thereby facilitating the upregulation of pro-inflammatory cytokines. Another adapter protein linked to TLR4, known as TRIF, autonomously propagates signaling pathways, resulting in heightened interferon expression. Recently, TLR4 has garnered attention as a significant factor in the regulation of symptoms in aging-related disorders. The persistent inflammatory response triggered by TLR4 contributes to the onset and exacerbation of these disorders. In addition, alterations in TLR4 expression levels play a pivotal role in modifying the manifestations of age-related diseases. In this review, we aim to consolidate the impact of TLR4 on cellular senescence and aging-related ailments, highlighting the potential of TLR4 as a novel therapeutic target that extends beyond immune responses.
format Online
Article
Text
id pubmed-10668412
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106684122023-11-24 Toll-like receptor 4 (TLR4): new insight immune and aging Kim, Hyo-Jin Kim, Hyemin Lee, Jeong-Hyung Hwangbo, Cheol Immun Ageing Review TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4 not only engages with exogenous ligands at the cellular membrane’s surface but also interacts with intracellular ligands, initiating intricate intracellular signaling cascades. Through MyD88, an adaptor protein, TLR4 activates transcription factors NF-κB and AP-1, thereby facilitating the upregulation of pro-inflammatory cytokines. Another adapter protein linked to TLR4, known as TRIF, autonomously propagates signaling pathways, resulting in heightened interferon expression. Recently, TLR4 has garnered attention as a significant factor in the regulation of symptoms in aging-related disorders. The persistent inflammatory response triggered by TLR4 contributes to the onset and exacerbation of these disorders. In addition, alterations in TLR4 expression levels play a pivotal role in modifying the manifestations of age-related diseases. In this review, we aim to consolidate the impact of TLR4 on cellular senescence and aging-related ailments, highlighting the potential of TLR4 as a novel therapeutic target that extends beyond immune responses. BioMed Central 2023-11-24 /pmc/articles/PMC10668412/ /pubmed/38001481 http://dx.doi.org/10.1186/s12979-023-00383-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Kim, Hyo-Jin
Kim, Hyemin
Lee, Jeong-Hyung
Hwangbo, Cheol
Toll-like receptor 4 (TLR4): new insight immune and aging
title Toll-like receptor 4 (TLR4): new insight immune and aging
title_full Toll-like receptor 4 (TLR4): new insight immune and aging
title_fullStr Toll-like receptor 4 (TLR4): new insight immune and aging
title_full_unstemmed Toll-like receptor 4 (TLR4): new insight immune and aging
title_short Toll-like receptor 4 (TLR4): new insight immune and aging
title_sort toll-like receptor 4 (tlr4): new insight immune and aging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668412/
https://www.ncbi.nlm.nih.gov/pubmed/38001481
http://dx.doi.org/10.1186/s12979-023-00383-3
work_keys_str_mv AT kimhyojin tolllikereceptor4tlr4newinsightimmuneandaging
AT kimhyemin tolllikereceptor4tlr4newinsightimmuneandaging
AT leejeonghyung tolllikereceptor4tlr4newinsightimmuneandaging
AT hwangbocheol tolllikereceptor4tlr4newinsightimmuneandaging